Assessment of research with material from an existing biobank.28 January 2021
If you want to perform research with material from a biobank and the initiation of this biobank has already been approved by the CMO Radboudumc, you only need to submit an application to the CMO Radboudumc for assessment in certain cases.
Financial regulation for sub-biobanks15 September 2020
Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.
Opt-out versus Opt-In Consent for Residual Samples17 October 2019
The Radboud Biobank will be conducting a 6-month feasibility study, as proposed by the Netherlands Federation of University Medical Centers (NFU), to evaluate the impact of migrating to a opt-in method, which requires explicit consent from the patient for use of the residual material.
Need a transfer agreement for external partners? For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.17 January 2019
For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.